semaglutide gastric paralysis Lawsuit Filed Against Ozempic, Mounjaro Over 'Stomach Paralysis' What We Know About Semaglutide

In November 2023, the Food and Drug Administration approved Zepbound, already available as diabetes medication Mounjaro, as a treatment for weight loss

doi:10.2147/NDS.S8043

Diarrhea, nausea, and vomiting are common side effects of Ozempic , all of which can cause dehydration, so remember to drink plenty of water throughout the day

Additionally, individuals with active or recent disordered eating patterns should avoid structured fasting while on appetite-suppressing medications, as the combination can trigger harmful behavioral patterns

While some weight loss with these medications isn't all fat, and some of it could be muscle, the good news is that you can help prevent muscle loss with proper dieting and exercise

PT-141 used outside the FDA-approved Vyleesi indication is off-label and not supported by Phase 3 evidence in those populations